190 related articles for article (PubMed ID: 36651691)
1. Response to sirolimus in capillary lymphatic venous malformations and associated syndromes: Impact on symptomatology, quality of life, and radiographic response.
Engel ER; Hammill A; Adams D; Phillips RJ; Jeng M; Tollefson MM; Iacobas I; Schiff D; Greenberger S; Kelly M; Frieden I; Zaghloul N; Drolet B; Geddis A; Goldenberg D; Ricci K
Pediatr Blood Cancer; 2023 Apr; 70(4):e30215. PubMed ID: 36651691
[TBL] [Abstract][Full Text] [Related]
2. Non-hotspot PIK3CA mutations are more frequent in CLOVES than in common or combined lymphatic malformations.
Brouillard P; Schlögel MJ; Homayun Sepehr N; Helaers R; Queisser A; Fastré E; Boutry S; Schmitz S; Clapuyt P; Hammer F; Dompmartin A; Weitz-Tuoretmaa A; Laranne J; Pasquesoone L; Vilain C; Boon LM; Vikkula M
Orphanet J Rare Dis; 2021 Jun; 16(1):267. PubMed ID: 34112235
[TBL] [Abstract][Full Text] [Related]
3. Targeted next-generation sequencing for detection of PIK3CA mutations in archival tissues from patients with Klippel-Trenaunay syndrome in an Asian population : List the full names and institutional addresses for all authors.
Sasaki Y; Ishikawa K; Hatanaka KC; Oyamada Y; Sakuhara Y; Shimizu T; Saito T; Murao N; Onodera T; Miura T; Maeda T; Funayama E; Hatanaka Y; Yamamoto Y; Sasaki S
Orphanet J Rare Dis; 2023 Sep; 18(1):270. PubMed ID: 37667289
[TBL] [Abstract][Full Text] [Related]
4. Klippel-Trenaunay syndrome belongs to the PIK3CA-related overgrowth spectrum (PROS).
Vahidnezhad H; Youssefian L; Uitto J
Exp Dermatol; 2016 Jan; 25(1):17-9. PubMed ID: 26268729
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary thromboembolic events in patients with congenital lipomatous overgrowth, vascular malformations, epidermal nevi, and spinal/skeletal abnormalities and Klippel-Trénaunay syndrome.
Reis J; Alomari AI; Trenor CC; Adams DM; Fishman SJ; Spencer SA; Shaikh R; Lillis AP; Surnedi MK; Chaudry G
J Vasc Surg Venous Lymphat Disord; 2018 Jul; 6(4):511-516. PubMed ID: 29909856
[TBL] [Abstract][Full Text] [Related]
6. Qualitative research with patients and caregivers of patients with PIK3CA related overgrowth spectrum: content validity of clinical outcome assessments.
Raymond K; Vallow S; Saucier C; Jackson K; White MK; Lovley A; D'Alessio D
J Patient Rep Outcomes; 2022 Jul; 6(1):75. PubMed ID: 35829859
[TBL] [Abstract][Full Text] [Related]
7. Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA.
Luks VL; Kamitaki N; Vivero MP; Uller W; Rab R; Bovée JV; Rialon KL; Guevara CJ; Alomari AI; Greene AK; Fishman SJ; Kozakewich HP; Maclellan RA; Mulliken JB; Rahbar R; Spencer SA; Trenor CC; Upton J; Zurakowski D; Perkins JA; Kirsh A; Bennett JT; Dobyns WB; Kurek KC; Warman ML; McCarroll SA; Murillo R
J Pediatr; 2015 Apr; 166(4):1048-54.e1-5. PubMed ID: 25681199
[TBL] [Abstract][Full Text] [Related]
8. Combined capillary-venous-lymphatic malformations without overgrowth in patients with Klippel-Trénaunay syndrome.
Brandigi E; Torino G; Messina M; Molinaro F; Mazzei O; Matucci T; López Gutiérrez JC
J Vasc Surg Venous Lymphat Disord; 2018 Mar; 6(2):230-236. PubMed ID: 29233587
[TBL] [Abstract][Full Text] [Related]
9. Pain, psychiatric comorbidities, and psychosocial stressors associated with Klippel-Trenaunay syndrome.
Harvey JA; Nguyen H; Anderson KR; Schoch JJ; Bendel EC; Driscoll DJ; Palmer BA; Tollefson MM
J Am Acad Dermatol; 2018 Nov; 79(5):899-903. PubMed ID: 29883592
[TBL] [Abstract][Full Text] [Related]
10. Options in the treatment of superficial and deep venous disease in patients with Klippel-Trenaunay syndrome.
Saleem T; Luke C; Raju S
J Vasc Surg Venous Lymphat Disord; 2022 Nov; 10(6):1343-1351.e3. PubMed ID: 35779829
[TBL] [Abstract][Full Text] [Related]
11. Causal somatic mutations in urine DNA from persons with the CLOVES subgroup of the PIK3CA-related overgrowth spectrum.
Michel ME; Konczyk DJ; Yeung KS; Murillo R; Vivero MP; Hall AM; Zurakowski D; Adams D; Gupta A; Huang AY; Chung BHY; Warman ML
Clin Genet; 2018 May; 93(5):1075-1080. PubMed ID: 29231959
[TBL] [Abstract][Full Text] [Related]
12. Diffuse capillary malformation with overgrowth: a clinical subtype of vascular anomalies with hypertrophy.
Lee MS; Liang MG; Mulliken JB
J Am Acad Dermatol; 2013 Oct; 69(4):589-94. PubMed ID: 23906555
[TBL] [Abstract][Full Text] [Related]
13. Constitutively active PIK3CA mutations are expressed by lymphatic and vascular endothelial cells in capillary lymphatic venous malformation.
Le Cras TD; Goines J; Lakes N; Pastura P; Hammill AM; Adams DM; Boscolo E
Angiogenesis; 2020 Aug; 23(3):425-442. PubMed ID: 32350708
[TBL] [Abstract][Full Text] [Related]
14. Wound-Healing Problems Associated with Combined Vascular Malformations in Klippel-Trenaunay Syndrome.
Ishikawa K; Yamamoto Y; Funayama E; Furukawa H; Sasaki S
Adv Wound Care (New Rochelle); 2019 Jun; 8(6):246-255. PubMed ID: 31832274
[No Abstract] [Full Text] [Related]
15. CLOVES syndrome: review of a PIK3CA-related overgrowth spectrum (PROS).
Martinez-Lopez A; Blasco-Morente G; Perez-Lopez I; Herrera-Garcia JD; Luque-Valenzuela M; Sanchez-Cano D; Lopez-Gutierrez JC; Ruiz-Villaverde R; Tercedor-Sanchez J
Clin Genet; 2017 Jan; 91(1):14-21. PubMed ID: 27426476
[TBL] [Abstract][Full Text] [Related]
16. High-Output Heart Failure in a Patient With Klippel-Trénaunay Syndrome: A Case Report.
Gubala A; Venkatesh K; Akhter M; Meyer TE; Fitzgibbons TP
Cureus; 2023 May; 15(5):e38963. PubMed ID: 37313059
[TBL] [Abstract][Full Text] [Related]
17. Somatic PIK3CA mutations in seven patients with PIK3CA-related overgrowth spectrum.
Yeung KS; Ip JJ; Chow CP; Kuong EY; Tam PK; Chan GC; Chung BH
Am J Med Genet A; 2017 Apr; 173(4):978-984. PubMed ID: 28328134
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolic and bleeding complications among pregnant women with Klippel-Trenaunay syndrome.
Marvin EK; Schoch JJ; Nguyen H; Anderson KR; Driscoll DJ; Rose CH; Bendel EC; Tollefson MM
J Am Acad Dermatol; 2019 Dec; 81(6):1277-1282. PubMed ID: 30991120
[TBL] [Abstract][Full Text] [Related]
19. [PIK3CA-related overgrowth syndrome (PROS)].
Venot Q; Canaud G
Nephrol Ther; 2017 Apr; 13 Suppl 1():S155-S156. PubMed ID: 28577738
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
